Best Practices for Interventional Cardiovascular Medical Device Trials

Interventional Cardio Device

Four Key Strategies to Manage Interventional Cardio Device Trials

While heart disease is the leading cause of death worldwide, thankfully significant advances in technology-based treatments for cardiovascular disease have been made in recent years. Sponsors seeking to bring implantable cardiovascular products to market face several significant factors in designing and conducting clinical trials; our paper addresses the four factors we consider most critical: regulatory requirements, reimbursement strategies, clinical challenges and vendor selection.

Submit this form for download. 

By submitting this form you agree to our Terms of Use and Privacy Policy. Information provided by you may be collected and automatically stored in our database and may be used for sending you additional information about Novella and our services. Such information also may be transferred to Novella companies in other countries.
Copyright © 2019 Novella Clinical and its affiliates. All rights reserved.